Simtuzumab Biosimilar – Anti-LOXL2 mAb – Research Grade

Reference:
Size

,

Isotype

IgG4, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameSimtuzumab Biosimilar - Anti-LOXL2 mAb - Research Grade
SourceCAS 1318075-13-6
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsSimtuzumab,AB0024,GS-6624,LOXL2,anti-LOXL2
ReferencePX-TA1303
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Simtuzumab Biosimilar - Anti-LOXL2 mAb - Research Grade

General information on Anti-LOXL2[Homo sapiens] (Simtuzumab) Monoclonal Antibody

Simtuzumab has beeninvestigated for the treatment of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.

SDS-PAGE for Simtuzumab Biosimilar - Anti-LOXL2 mAb

Simtuzumab Biosimilar - Anti-LOXL2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Simtuzumab Biosimilar – Anti-LOXL2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human LOXL2 recombinant protein
Antigen

Human LOXL2 recombinant protein

PX-P6142 500$
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products